COVID-19 Vaccine Effectiveness for Pregnant Women, Newborns Plummets During Omicron: CDC Data

COVID-19 Vaccine Effectiveness for Pregnant Women, Newborns Plummets During Omicron: CDC Data
A health care worker prepares Pfizer COVID-19 vaccine doses in Portland, Ore., in a file photograph. Nathan Howard/Getty Images
Zachary Stieber
Zachary Stieber
Senior Reporter
|Updated:
0:00

COVID-19 vaccine effectiveness has plummeted for pregnant women and newborns since the Omicron coronavirus variant became the dominant strain in the United States, according to data presented by Centers for Disease Control and Prevention (CDC) officials on Oct. 19.

The effectiveness of two doses of a Pfizer or Moderna vaccine against emergency department and urgent care visits was 87 percent after two doses and remained high at 78 percent after 150 or more days while the Delta variant was predominant, according to data from the CDC-funded VISION network.

Zachary Stieber
Zachary Stieber
Senior Reporter
Zachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news. Contact Zachary at [email protected]
twitter
truth
Related Topics